NO20060776L - Muskarine acetylkolinreseptorantagonister - Google Patents

Muskarine acetylkolinreseptorantagonister

Info

Publication number
NO20060776L
NO20060776L NO20060776A NO20060776A NO20060776L NO 20060776 L NO20060776 L NO 20060776L NO 20060776 A NO20060776 A NO 20060776A NO 20060776 A NO20060776 A NO 20060776A NO 20060776 L NO20060776 L NO 20060776L
Authority
NO
Norway
Prior art keywords
receptor antagonists
acetylcholine receptor
muscarine
muscarine acetylcholine
methods
Prior art date
Application number
NO20060776A
Other languages
English (en)
Norwegian (no)
Inventor
Kristen E Belmonte
Jakob Busch-Petersen
Dramane I Laine
Michael R Palovich
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20060776L publication Critical patent/NO20060776L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20060776A 2003-07-17 2006-02-17 Muskarine acetylkolinreseptorantagonister NO20060776L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48806103P 2003-07-17 2003-07-17
PCT/US2004/023042 WO2005009440A1 (fr) 2003-07-17 2004-07-16 Antagonistes du recepteur de l'acetylcholine muscarinique

Publications (1)

Publication Number Publication Date
NO20060776L true NO20060776L (no) 2006-04-11

Family

ID=34102742

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060776A NO20060776L (no) 2003-07-17 2006-02-17 Muskarine acetylkolinreseptorantagonister

Country Status (18)

Country Link
US (1) US20060160844A1 (fr)
EP (1) EP1648462A4 (fr)
JP (1) JP2007535477A (fr)
KR (1) KR20060054317A (fr)
CN (1) CN1822840A (fr)
AR (1) AR048573A1 (fr)
AU (1) AU2004259239A1 (fr)
BR (1) BRPI0412679A (fr)
CA (1) CA2532379A1 (fr)
IL (1) IL172911A0 (fr)
IS (1) IS8297A (fr)
MA (1) MA27973A1 (fr)
MX (1) MXPA06000664A (fr)
NO (1) NO20060776L (fr)
PE (1) PE20050711A1 (fr)
RU (1) RU2006104854A (fr)
TW (1) TW200519109A (fr)
WO (1) WO2005009440A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045914A1 (es) * 2003-07-17 2005-11-16 Glaxo Group Ltd Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
SI1677795T1 (sl) 2003-10-14 2011-04-29 Glaxo Group Ltd Antagonisti muskarinskega acetilholinskega receptorja
EP1677796A4 (fr) * 2003-10-17 2006-12-27 Glaxo Group Ltd Antagonistes du recepteur acetylcholine muscarinique
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
WO2005087236A1 (fr) * 2004-03-11 2005-09-22 Glaxo Group Limited Nouveaux antagonistes du recepteur de l'acetylcholine muscarinique m3
US7384946B2 (en) * 2004-03-17 2008-06-10 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
EP1725238A4 (fr) * 2004-03-17 2009-04-01 Glaxo Group Ltd Antagonistes du recepteur muscarinique a l'acetylcholine m 3
UY28871A1 (es) 2004-04-27 2005-11-30 Glaxo Group Ltd Antagonistas del receptor de acetilcolina muscarinico
EP1747219A4 (fr) * 2004-05-13 2010-05-26 Glaxo Group Ltd Domaine de l'invention antagonistes récepteurs d'acétyle choline muscarinique
JP2008520579A (ja) * 2004-11-15 2008-06-19 グラクソ グループ リミテッド 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
DE602006021297D1 (de) * 2005-06-10 2011-05-26 Us Government Benztropinamin-analoge als dopamin-aufnahmehemmer
US20080275079A1 (en) * 2005-08-02 2008-11-06 Glaxo Group Limited M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007022351A2 (fr) 2005-08-18 2007-02-22 Glaxo Group Limited Antagonistes de recepteurs d'acetylcholine muscarinique
EP1919476A2 (fr) 2005-08-24 2008-05-14 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Derives de benzotropine et leurs utilisations comme inhibiteurs de recapture de la dopamine
AR070563A1 (es) 2008-02-06 2010-04-21 Glaxo Group Ltd Compuesto de un biciclo condensado pirazol-piridin-amina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de enfermedades respiratorias.
PE20091552A1 (es) 2008-02-06 2009-10-25 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
WO2010094643A1 (fr) 2009-02-17 2010-08-26 Glaxo Group Limited Dérivés de quinoline et applications associées dans la rhinite et l'urticaire

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800482A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CA2415468A1 (fr) * 2000-07-11 2003-01-10 Yoshio Ogino Derives d'ester
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
RU2004110717A (ru) * 2001-10-17 2005-10-20 Юсиби, С.А. (Be) Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов
ES2329586T3 (es) * 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.

Also Published As

Publication number Publication date
US20060160844A1 (en) 2006-07-20
JP2007535477A (ja) 2007-12-06
KR20060054317A (ko) 2006-05-22
CA2532379A1 (fr) 2005-02-03
CN1822840A (zh) 2006-08-23
AU2004259239A1 (en) 2005-02-03
AR048573A1 (es) 2006-05-10
IL172911A0 (en) 2006-06-11
IS8297A (is) 2006-02-13
TW200519109A (en) 2005-06-16
EP1648462A1 (fr) 2006-04-26
BRPI0412679A (pt) 2006-10-03
WO2005009440A1 (fr) 2005-02-03
MA27973A1 (fr) 2006-07-03
RU2006104854A (ru) 2006-06-27
EP1648462A4 (fr) 2009-04-08
PE20050711A1 (es) 2005-09-10
MXPA06000664A (es) 2006-03-30

Similar Documents

Publication Publication Date Title
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
NO20062042L (no) Muskariniske acetylkolin reseptorantangonister
UY28598A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
NO20060775L (no) Muskarine acetylkolinreseptorantagonister
UY27927A1 (es) Antagonistas del receptor muscarínico m3 de acetilcolina
NO20060777L (no) Muskarine acetylkolinreseptorantagonister
NO20063032L (no) Nye M3 muskarinacetylkolinreceptorantagoniser
TW200600093A (en) M3 muscarinic acetylcholine receptor antagonists
NO20062992L (no) Nye M3 muskarine acetykolinreseptorantagonister
BRPI0506777A (pt) antagonistas do receptor muscarìnico da acetilcolina
BRPI0412679A (pt) antagonistas de receptor muscarìnico de acetilcolina
WO2007022351A3 (fr) Antagonistes de recepteurs d&#39;acetylcholine muscarinique
UY28567A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
TW200600500A (en) M3 muscarinic acetylcholine receptor antagonists
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
WO2007016639A3 (fr) Antagonistes des recepteurs de l&#39; acetylcholine muscarinique m3
WO2007016650A3 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique m3
UY28557A1 (es) Antagonistas de receptores de acetilcolina muscarinicos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application